Enveric Biosciences, Inc. (ENVB)
5.44
-4.89
(-47.34%)
USD |
NASDAQ |
Dec 11, 16:00
5.73
+0.29
(+5.33%)
After-Hours: 20:00
Enveric Biosciences EPS Diluted (Quarterly): -10.81 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 0.0993 |
| Pasithea Therapeutics Corp. | -0.4081 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.874M |
| Total Expenses (Quarterly) | 1.874M |
| Enterprise Value | -0.938M |
| Earnings Yield | -1.50K% |
| Normalized Earnings Yield | -1499.28 |